| Q112760914 | ARHGEF18/p114RhoGEF Coordinates PKA/CREB Signaling and Actomyosin Remodeling to Promote Trophoblast Cell-Cell Fusion During Placenta Morphogenesis |
| Q77932483 | Activation of protein kinase C by oxytocin inhibits the biological activity of the human myometrial corticotropin-releasing hormone receptor at term |
| Q91956993 | Antenatal screening for fetal trisomies using microarray-based cell-free DNA testing: A systematic review and meta-analysis |
| Q48292764 | Authors response to Stergiakouli et al. |
| Q96126992 | Bacteriophage K1F targets Escherichia coli K1 in cerebral endothelial cells and influences the barrier function |
| Q51181101 | CRH Receptor Signalling: Potential Roles in Pathophysiology. |
| Q42366650 | CRH-R splicing in estrogen-sensitive breast cancer |
| Q37995212 | Characterising the corticotropin-releasing hormone (CRH) receptors mediating CRH and urocortin actions during human pregnancy and labour. |
| Q54417332 | Characterization of Structural Determinants of Type 1 Corticotropin Releasing Hormone (CRH) Receptor Signalling Properties |
| Q39458387 | Corticotropin-Releasing Hormone As the Homeostatic Rheostat of Feto-Maternal Symbiosis and Developmental Programming In Utero and Neonatal Life |
| Q37424706 | Corticotropin-releasing hormone interacts with interleukin-1β to regulate prostaglandin H synthase-2 expression in human myometrium during pregnancy and labor. |
| Q43678571 | Cyclic AMP enhances progesterone action in human myometrial cells. |
| Q90423116 | Determining the stress biomarker profile in patients undergoing total knee replacement and the relationship with outcome at 12 months |
| Q39131186 | Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells. |
| Q44757840 | Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. |
| Q28589255 | Extra-nuclear telomerase reverse transcriptase (TERT) regulates glucose transport in skeletal muscle cells |
| Q90532922 | Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management |
| Q28214775 | Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists |
| Q47142152 | Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET). |
| Q36450097 | Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia |
| Q47856062 | Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. |
| Q52795185 | Hypertestosteronemia and Infertility from a Mediastinal Extragonadal Germ Cell Tumor. |
| Q58705449 | Improved Thyroid Hypoechogenicity Following Bariatric-Induced Weight Loss in Euthyroid Adults With Severe Obesity-a Pilot Study |
| Q34140178 | Inhibition of Akt activity and calcium channel function coordinately drive cell-cell fusion in the BeWO choriocarcinoma placental cell line |
| Q36153237 | Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. |
| Q39638147 | Interplay of cAMP and MAPK pathways in hCG secretion and fusogenic gene expression in a trophoblast cell line. |
| Q33643265 | Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. |
| Q48041969 | Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy |
| Q58707864 | Modelling of psychosocial and lifestyle predictors of peripartum depressive symptoms associated with distinct risk trajectories: a prospective cohort study |
| Q83455153 | Molecular determinants and feedback circuits regulating type 2 CRH receptor signal integration |
| Q87044190 | Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays |
| Q36996530 | Pathological interactions with the timing of birth and uterine activation. |
| Q43927127 | Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. |
| Q46398451 | Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides |
| Q44681184 | Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. |
| Q54796134 | Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas. |
| Q39147632 | Regulation of G-protein coupled receptor signalling underpinning neurobiology of mood disorders and depression. |
| Q73156512 | Role of corticotropin-releasing hormone in onset of labour |
| Q36238550 | Severe paraneoplastic hypoglycemia secondary to a gastrointestinal stromal tumour masquerading as a stroke |
| Q73867044 | Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit |
| Q40072646 | Structural domains determining signalling characteristics of the CRH-receptor type 1 variant R1beta and response to PKC phosphorylation. |
| Q58450573 | The Onset of Labor Alters Corticotropin-Releasing Hormone Type 1 Receptor Variant Expression in Human Myometrium: Putative Role of Interleukin-1β |
| Q71091928 | The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy |
| Q42796049 | The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms |
| Q72524969 | The human myometrial CRH receptor: G proteins and second messengers |
| Q71942329 | The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor |
| Q74446091 | The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1alpha (CRH-1alpha) and the CRH-C variant receptor |
| Q52400364 | The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. |
| Q37551852 | The identification of mitochondrial DNA variants in glioblastoma multiforme |
| Q36399313 | The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. |
| Q34207325 | The role of corticotropin-releasing hormone receptors in placenta and fetal membranes during human pregnancy. |
| Q34017553 | Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells |
| Q28181044 | Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility |
| Q40837517 | Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq- |